Blackstone Life Sciences
Cambridge, Massachusettsblackstone.com
Overview
Blackstone Life Sciences is an industry-leading private investment platform with capabilities to invest across the life cycle of companies and products within the key life science sectors . By combining scale investments and hands-on operational leadership, Blackstone Life Sciences helps bring to market promising new medicines and medical technologies that improve patients' lives .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Anagram Therapeutics Inc. | May 2026 | Early Funding | Lead |
| GRIN Therapeutics, Inc. | May 2025 | Series D | Lead |
| Neurvati Neurosciences | May 2025 | Series D | Lead |
| AvenCell | Oct 2024 | Series B | Co-investor |
| Uniquity Bio | May 2024 | Private Equity | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
